back to cluster viewer
cluster path 111010111110111
117 words, 8,898 tokens
freq alpha suffix
Words in frequency order
1 | much | 8,711
|
2 | 'much | 31
|
3 | much/much | 6
|
4 | orders-of-magnitude | 6
|
5 | 1.67-fold | 4
|
6 | inclining | 4
|
7 | 'business | 3
|
8 | 2.5-times | 3
|
9 | ly-30 | 3
|
10 | markly | 3
|
11 | samphel | 3
|
12 | 'somewhat | 2
|
13 | 14-times | 2
|
14 | 2g/l | 2
|
15 | 3.7-month | 2
|
16 | borderline-significantly | 2
|
17 | easy/very | 2
|
18 | improved/not | 2
|
19 | mirror-touch | 2
|
20 | nonplantar | 2
|
21 | phytocomplex | 2
|
22 | sisted | 2
|
23 | tantalizingly | 2
|
24 | technobiopower | 2
|
25 | tetroxoprim | 2
|
26 | undisputedly | 2
|
27 | 'genuine | 1
|
28 | 0.05-unit | 1
|
29 | 0.19-kj/min | 1
|
30 | 0.2055 | 1
|
31 | 0.6-h | 1
|
32 | 0.7-month | 1
|
33 | 0.91kg | 1
|
34 | 0·7–0·8 | 1
|
35 | 1.35s | 1
|
36 | 1.9× | 1
|
37 | 10.41° | 1
|
38 | 100-1,000-fold | 1
|
39 | 13.8°c | 1
|
40 | 150g | 1
|
41 | 2-5-fold | 1
|
42 | 2.1-3.6-fold | 1
|
43 | 28kg | 1
|
44 | 3-11-fold | 1
|
45 | 4.5× | 1
|
46 | 58-fold | 1
|
47 | 6.75-fold | 1
|
48 | 7.5/8.8-fold | 1
|
49 | 77-times | 1
|
50 | 9649 | 1
|
51 | admiring | 1
|
52 | afro-surinamers | 1
|
53 | assumedly | 1
|
54 | backslab | 1
|
55 | bargains | 1
|
56 | better/much | 1
|
57 | bioethically | 1
|
58 | catagories | 1
|
59 | chemo-sero-therapeutic | 1
|
60 | conventionalizes | 1
|
61 | enactors | 1
|
62 | endopelvicfascie | 1
|
63 | ever-increasingly | 1
|
64 | fev1/fev1-predicted | 1
|
65 | ff50 | 1
|
66 | ff60 | 1
|
67 | frequently-were | 1
|
68 | functionally-connected | 1
|
69 | further- | 1
|
70 | guanghzou | 1
|
71 | hfpef- | 1
|
72 | hg/decade | 1
|
73 | imbue | 1
|
74 | immunomodulators-and | 1
|
75 | improved/greatly | 1
|
76 | incomparably | 1
|
77 | it-m. | 1
|
78 | limited.evaluations | 1
|
79 | lobo | 1
|
80 | microanastomoses | 1
|
81 | mk-8267 | 1
|
82 | neoceratodus | 1
|
83 | neverthe- | 1
|
84 | noromosyslolia | 1
|
85 | not-quite-significant | 1
|
86 | numerously | 1
|
87 | olduvai | 1
|
88 | orientals | 1
|
89 | pa−1 | 1
|
90 | ph2o | 1
|
91 | process-mechanism | 1
|
92 | rywaroxaban | 1
|
93 | siderably | 1
|
94 | sig-nificantly | 1
|
95 | sightly | 1
|
96 | silghtly | 1
|
97 | slides-a | 1
|
98 | slightly/significantly | 1
|
99 | stool-gas | 1
|
100 | substanti-ally | 1
|
101 | suppression-induced | 1
|
102 | symptom-free/markedly | 1
|
103 | system-orientated | 1
|
104 | tes-particularly | 1
|
105 | themself | 1
|
106 | transition-metal-grafted | 1
|
107 | trialkylsilanes | 1
|
108 | usd634 | 1
|
109 | very/fairly | 1
|
110 | viscera-state | 1
|
111 | £1522 | 1
|
112 | £214.49 | 1
|
113 | ×32 | 1
|
114 | €2841 | 1
|
115 | ∼35-second | 1
|
116 | ∼3× | 1
|
117 | ≈7-fold | 1
|
Words in alphabetical order
1 | 'business | 3
|
2 | 'genuine | 1
|
3 | 'much | 31
|
4 | 'somewhat | 2
|
5 | 0.05-unit | 1
|
6 | 0.19-kj/min | 1
|
7 | 0.2055 | 1
|
8 | 0.6-h | 1
|
9 | 0.7-month | 1
|
10 | 0.91kg | 1
|
11 | 0·7–0·8 | 1
|
12 | 1.35s | 1
|
13 | 1.67-fold | 4
|
14 | 1.9× | 1
|
15 | 10.41° | 1
|
16 | 100-1,000-fold | 1
|
17 | 13.8°c | 1
|
18 | 14-times | 2
|
19 | 150g | 1
|
20 | 2-5-fold | 1
|
21 | 2.1-3.6-fold | 1
|
22 | 2.5-times | 3
|
23 | 28kg | 1
|
24 | 2g/l | 2
|
25 | 3-11-fold | 1
|
26 | 3.7-month | 2
|
27 | 4.5× | 1
|
28 | 58-fold | 1
|
29 | 6.75-fold | 1
|
30 | 7.5/8.8-fold | 1
|
31 | 77-times | 1
|
32 | 9649 | 1
|
33 | admiring | 1
|
34 | afro-surinamers | 1
|
35 | assumedly | 1
|
36 | backslab | 1
|
37 | bargains | 1
|
38 | better/much | 1
|
39 | bioethically | 1
|
40 | borderline-significantly | 2
|
41 | catagories | 1
|
42 | chemo-sero-therapeutic | 1
|
43 | conventionalizes | 1
|
44 | easy/very | 2
|
45 | enactors | 1
|
46 | endopelvicfascie | 1
|
47 | ever-increasingly | 1
|
48 | fev1/fev1-predicted | 1
|
49 | ff50 | 1
|
50 | ff60 | 1
|
51 | frequently-were | 1
|
52 | functionally-connected | 1
|
53 | further- | 1
|
54 | guanghzou | 1
|
55 | hfpef- | 1
|
56 | hg/decade | 1
|
57 | imbue | 1
|
58 | immunomodulators-and | 1
|
59 | improved/greatly | 1
|
60 | improved/not | 2
|
61 | inclining | 4
|
62 | incomparably | 1
|
63 | it-m. | 1
|
64 | limited.evaluations | 1
|
65 | lobo | 1
|
66 | ly-30 | 3
|
67 | markly | 3
|
68 | microanastomoses | 1
|
69 | mirror-touch | 2
|
70 | mk-8267 | 1
|
71 | much | 8,711
|
72 | much/much | 6
|
73 | neoceratodus | 1
|
74 | neverthe- | 1
|
75 | nonplantar | 2
|
76 | noromosyslolia | 1
|
77 | not-quite-significant | 1
|
78 | numerously | 1
|
79 | olduvai | 1
|
80 | orders-of-magnitude | 6
|
81 | orientals | 1
|
82 | pa−1 | 1
|
83 | ph2o | 1
|
84 | phytocomplex | 2
|
85 | process-mechanism | 1
|
86 | rywaroxaban | 1
|
87 | samphel | 3
|
88 | siderably | 1
|
89 | sig-nificantly | 1
|
90 | sightly | 1
|
91 | silghtly | 1
|
92 | sisted | 2
|
93 | slides-a | 1
|
94 | slightly/significantly | 1
|
95 | stool-gas | 1
|
96 | substanti-ally | 1
|
97 | suppression-induced | 1
|
98 | symptom-free/markedly | 1
|
99 | system-orientated | 1
|
100 | tantalizingly | 2
|
101 | technobiopower | 2
|
102 | tes-particularly | 1
|
103 | tetroxoprim | 2
|
104 | themself | 1
|
105 | transition-metal-grafted | 1
|
106 | trialkylsilanes | 1
|
107 | undisputedly | 2
|
108 | usd634 | 1
|
109 | very/fairly | 1
|
110 | viscera-state | 1
|
111 | £1522 | 1
|
112 | £214.49 | 1
|
113 | ×32 | 1
|
114 | €2841 | 1
|
115 | ∼35-second | 1
|
116 | ∼3× | 1
|
117 | ≈7-fold | 1
|
Words in suffix order
1 | neverthe- | 1
|
2 | hfpef- | 1
|
3 | further- | 1
|
4 | it-m. | 1
|
5 | ly-30 | 3
|
6 | ff50 | 1
|
7 | ff60 | 1
|
8 | €2841 | 1
|
9 | pa−1 | 1
|
10 | £1522 | 1
|
11 | ×32 | 1
|
12 | usd634 | 1
|
13 | 0.2055 | 1
|
14 | mk-8267 | 1
|
15 | 0·7–0·8 | 1
|
16 | £214.49 | 1
|
17 | 9649 | 1
|
18 | slides-a | 1
|
19 | noromosyslolia | 1
|
20 | backslab | 1
|
21 | chemo-sero-therapeutic | 1
|
22 | 13.8°c | 1
|
23 | suppression-induced | 1
|
24 | system-orientated | 1
|
25 | functionally-connected | 1
|
26 | fev1/fev1-predicted | 1
|
27 | transition-metal-grafted | 1
|
28 | sisted | 2
|
29 | 100-1,000-fold | 1
|
30 | 3-11-fold | 1
|
31 | 2-5-fold | 1
|
32 | 6.75-fold | 1
|
33 | 2.1-3.6-fold | 1
|
34 | 1.67-fold | 4
|
35 | ≈7-fold | 1
|
36 | 7.5/8.8-fold | 1
|
37 | 58-fold | 1
|
38 | immunomodulators-and | 1
|
39 | ∼35-second | 1
|
40 | hg/decade | 1
|
41 | orders-of-magnitude | 6
|
42 | endopelvicfascie | 1
|
43 | 'genuine | 1
|
44 | frequently-were | 1
|
45 | viscera-state | 1
|
46 | imbue | 1
|
47 | themself | 1
|
48 | 150g | 1
|
49 | 0.91kg | 1
|
50 | 28kg | 1
|
51 | inclining | 4
|
52 | admiring | 1
|
53 | 0.6-h | 1
|
54 | much | 8,711
|
55 | 'much | 31
|
56 | much/much | 6
|
57 | better/much | 1
|
58 | mirror-touch | 2
|
59 | 0.7-month | 1
|
60 | 3.7-month | 2
|
61 | olduvai | 1
|
62 | 2g/l | 2
|
63 | samphel | 3
|
64 | tetroxoprim | 2
|
65 | process-mechanism | 1
|
66 | rywaroxaban | 1
|
67 | 0.19-kj/min | 1
|
68 | ph2o | 1
|
69 | lobo | 1
|
70 | nonplantar | 2
|
71 | technobiopower | 2
|
72 | 1.35s | 1
|
73 | stool-gas | 1
|
74 | catagories | 1
|
75 | 14-times | 2
|
76 | 2.5-times | 3
|
77 | 77-times | 1
|
78 | trialkylsilanes | 1
|
79 | microanastomoses | 1
|
80 | conventionalizes | 1
|
81 | orientals | 1
|
82 | bargains | 1
|
83 | limited.evaluations | 1
|
84 | afro-surinamers | 1
|
85 | enactors | 1
|
86 | 'business | 3
|
87 | neoceratodus | 1
|
88 | 'somewhat | 2
|
89 | 0.05-unit | 1
|
90 | not-quite-significant | 1
|
91 | improved/not | 2
|
92 | guanghzou | 1
|
93 | phytocomplex | 2
|
94 | incomparably | 1
|
95 | siderably | 1
|
96 | symptom-free/markedly | 1
|
97 | assumedly | 1
|
98 | undisputedly | 2
|
99 | ever-increasingly | 1
|
100 | tantalizingly | 2
|
101 | markly | 3
|
102 | substanti-ally | 1
|
103 | bioethically | 1
|
104 | tes-particularly | 1
|
105 | very/fairly | 1
|
106 | numerously | 1
|
107 | improved/greatly | 1
|
108 | sightly | 1
|
109 | silghtly | 1
|
110 | sig-nificantly | 1
|
111 | borderline-significantly | 2
|
112 | slightly/significantly | 1
|
113 | easy/very | 2
|
114 | ∼3× | 1
|
115 | 4.5× | 1
|
116 | 1.9× | 1
|
117 | 10.41° | 1
|